Minjiang Chen

Boyuan Peng, Jiaju Chen, P. Bilha Githinji et al.

Cell segmentation is essential in biomedical research for analyzing cellular morphology and behavior. Deep learning methods, particularly convolutional neural networks (CNNs), have revolutionized cell segmentation by extracting intricate features from images. However, the robustness of these methods under microscope optical aberrations remains a critical challenge. This study evaluates cell image segmentation models under optical aberrations from fluorescence and bright field microscopy. By simulating different types of aberrations, including astigmatism, coma, spherical aberration, trefoil, and mixed aberrations, we conduct a thorough evaluation of various cell instance segmentation models using the DynamicNuclearNet (DNN) and LIVECell datasets, representing fluorescence and bright field microscopy cell datasets, respectively. We train and test several segmentation models, including the Otsu threshold method and Mask R-CNN with different network heads (FPN, C3) and backbones (ResNet, VGG, Swin Transformer), under aberrated conditions. Additionally, we provide usage recommendations for the Cellpose 2.0 Toolbox on complex cell degradation images. The results indicate that the combination of FPN and SwinS demonstrates superior robustness in handling simple cell images affected by minor aberrations. In contrast, Cellpose 2.0 proves effective for complex cell images under similar conditions. Furthermore, we innovatively propose the Point Spread Function Image Label Classification Model (PLCM). This model can quickly and accurately identify aberration types and amplitudes from PSF images, assisting researchers without optical training. Through PLCM, researchers can better apply our proposed cell segmentation guidelines.

Jiaming Deng, Zhenglin Chen, Minjiang Chen et al.

Mycoplasma pneumoniae pneumonia (MPP) poses significant diagnostic challenges in pediatric healthcare, especially in regions like China where it's prevalent. We introduce PneumoniaAPP, a mobile application leveraging deep learning techniques for rapid MPP detection. Our approach capitalizes on convolutional neural networks (CNNs) trained on a comprehensive dataset comprising 3345 chest X-ray (CXR) images, which includes 833 CXR images revealing MPP and additionally augmented with samples from a public dataset. The CNN model achieved an accuracy of 88.20% and an AUROC of 0.9218 across all classes, with a specific accuracy of 97.64% for the mycoplasma class, as demonstrated on the testing dataset. Furthermore, we integrated explainability techniques into PneumoniaAPP to aid respiratory physicians in lung opacity localization. Our contribution extends beyond existing research by targeting pediatric MPP, emphasizing the age group of 0-12 years, and prioritizing deployment on mobile devices. This work signifies a significant advancement in pediatric pneumonia diagnosis, offering a reliable and accessible tool to alleviate diagnostic burdens in healthcare settings.

Muhammad Akmal Raheem, Muhammad Ajwad Rahim, Ijaz Gul et al.

SARS-CoV-2, the highly contagious pathogen responsible for the COVID-19 pandemic, has persistent effects that begin four weeks after initial infection and last for an undetermined duration. These chronic effects are more harmful than acute ones. This review explores the long-term impact of the virus on various human organs, including the pulmonary, cardiovascular, neurological, reproductive, gastrointestinal, musculoskeletal, endocrine, and lymphoid systems, particularly in older adults. Regarding diagnosis, RT-PCR is the gold standard for detecting COVID-19, though it requires specialized equipment, skilled personnel, and considerable time to produce results. To address these limitations, artificial intelligence in imaging and microfluidics technologies offers promising alternatives for diagnosing COVID-19 efficiently. Pharmacological and non-pharmacological strategies are effective in mitigating the persistent impacts of COVID-19. These strategies enhance immunity in post-COVID-19 patients by reducing cytokine release syndrome, improving T cell response, and increasing the circulation of activated natural killer and CD8 T cells in blood and tissues. This, in turn, alleviates symptoms such as fever, nausea, fatigue, muscle weakness, and pain. Vaccines, including inactivated viral, live attenuated viral, protein subunit, viral vectored, mRNA, DNA, and nanoparticle vaccines, significantly reduce the adverse long-term effects of the virus. However, no vaccine has been reported to provide lifetime protection against COVID-19. Consequently, protective measures such as physical distancing, mask usage, and hand hygiene remain essential strategies. This review offers a comprehensive understanding of the persistent effects of COVID-19 on individuals of varying ages, along with insights into diagnosis, treatment, vaccination, and future preventative measures against the spread of SARS-CoV-2.